Radioimmunoassay of human parathyroid hormone in serum.
PDF (1.9M)
Journal: 1971/April - Journal of Clinical Investigation
ISSN: 0021-9738
Abstract:
A new radioimmunoassay for human parathyroid hormone (PTH) in serum, which can measure the hormone present in 94% of the normal sera tested, is described. It is based on the ability of human PTH to compete with (131)I-labeled bovine PTH for binding to an antiserum directed against porcine PTH. This antiserum distinguishes between human PTH extracted from parathyroid adenomata and that present in hyperparathyroid sera. Evidence is given to suggest that this is due to immunochemical changes in the hormone extracted from adenomata and not to immunochemical heterogeneity of the hormone present in serum. Physiologic data supporting the validity and specificity of the assay are presented. Induced episodes of hypercalcemia and hypocalcemia resulted in appropriate responses in serum immunoreactive PTH (IPTH) in normal subjects and in patients with Paget's disease of bone. In normals, there was a progressive increase in serum IPTH in the late afternoon and evening, suggesting a diurnal secretory rhythm. A negative correlation was found between the serum calcium and serum IPTH over the normal range of serum calcium values; a positive correlation was found between these variables in patients with primary hyperparathyroidism. There was apparent overlap between serum IPTH values in normal subjects and patients with primary hyperparathyroidism, but formal discriminate analysis of values for serum calcium and IPTH demonstrated separation of these two groups, without overlap.
Open in
PUBMED | DOI | PMC | Google Scholar | Wikipedia
Relations:
Content
Citations
(96)
References
(23)
Diseases
(1)
Chemicals
(3)
Organisms
(1)
Processes
(2)
Similar articles
Articles by the same authors
Discussion board
J Clin Invest 50(1): 21-34
PMID: 5543877

Radioimmunoassay of human parathyroid hormone in serum

Abstract

A new radioimmunoassay for human parathyroid hormone (PTH) in serum, which can measure the hormone present in 94% of the normal sera tested, is described. It is based on the ability of human PTH to compete with I-labeled bovine PTH for binding to an antiserum directed against porcine PTH. This antiserum distinguishes between human PTH extracted from parathyroid adenomata and that present in hyperparathyroid sera. Evidence is given to suggest that this is due to immunochemical changes in the hormone extracted from adenomata and not to immunochemical heterogeneity of the hormone present in serum.

Physiologic data supporting the validity and specificity of the assay are presented. Induced episodes of hypercalcemia and hypocalcemia resulted in appropriate responses in serum immunoreactive PTH (IPTH) in normal subjects and in patients with Paget's disease of bone. In normals, there was a progressive increase in serum IPTH in the late afternoon and evening, suggesting a diurnal secretory rhythm. A negative correlation was found between the serum calcium and serum IPTH over the normal range of serum calcium values; a positive correlation was found between these variables in patients with primary hyperparathyroidism. There was apparent overlap between serum IPTH values in normal subjects and patients with primary hyperparathyroidism, but formal discriminate analysis of values for serum calcium and IPTH demonstrated separation of these two groups, without overlap.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1.9M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.
icon of scanned page 21
21
icon of scanned page 22
22
icon of scanned page 23
23
icon of scanned page 24
24
icon of scanned page 25
25
icon of scanned page 26
26
icon of scanned page 27
27
icon of scanned page 28
28
icon of scanned page 29
29
icon of scanned page 30
30
icon of scanned page 31
31
icon of scanned page 32
32
icon of scanned page 33
33
icon of scanned page 34
34

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Reiss E. Measurement of parathyroid hormone. Ann Intern Med. 1968 Dec;69(6):1325–1326. [PubMed] [Google Scholar]
  • Berson SA, Yalow RS. Immunochemical heterogeneity of parathyroid hormone in plasma. J Clin Endocrinol Metab. 1968 Jul;28(7):1037–1047. [PubMed] [Google Scholar]
  • Reis E, Canterbury JM. A radioimmunoassay for parathyroid hormone in man. Proc Soc Exp Biol Med. 1968 Jun;128(2):501–504. [PubMed] [Google Scholar]
  • Reiss E, Canterbury JM, Egdahl RH. Experience with a radioimmunoassay of parathyroid hormone in human sera. Trans Assoc Am Physicians. 1968;81:104–115. [PubMed] [Google Scholar]
  • Berson SA, Yalow RS, Aurbach GD, Potts JT. IMMUNOASSAY OF BOVINE AND HUMAN PARATHYROID HORMONE. Proc Natl Acad Sci U S A. 1963 May;49(5):613–617.[PMC free article] [PubMed] [Google Scholar]
  • Berson SA, Yalow RS. Parathyroid hormone in plasma in adenomatous hyperparathyroidism, uremia, and bronchogenic carcinoma. Science. 1966 Nov 18;154(3751):907–909. [PubMed] [Google Scholar]
  • Tashjian AH, Jr, Frantz AG, Lee JB. Pseudohypoparathyroidism: assays of parathyroid hormone and thyrocalcitonin. Proc Natl Acad Sci U S A. 1966 Oct;56(4):1138–1142.[PMC free article] [PubMed] [Google Scholar]
  • Littledike ET, Hawker CD. Extraction, purification and partial characterization of porcine parathyroid hormone. Endocrinology. 1967 Aug;81(2):261–266. [PubMed] [Google Scholar]
  • RASMUSSEN H, SZE YL, YOUNG R. FURTHER STUDIES ON THE ISOLATION AND CHARACTERIZATION OF PARATHYROID POLYPEPTIDES. J Biol Chem. 1964 Sep;239:2852–2857. [PubMed] [Google Scholar]
  • Hawker CD, Glass JD, Rasmussen H. Further studies on the isolation and charcterization of parathyroid polypeptides. Biochemistry. 1966 Jan;5(1):344–352. [PubMed] [Google Scholar]
  • Berson SA, Yalow RS. Iodoinsulin used to determine specific activity of iodine-131. Science. 1966 Apr 8;152(3719):205–207. [PubMed] [Google Scholar]
  • HUNTER WM, GREENWOOD FC. Preparation of iodine-131 labelled human growth hormone of high specific activity. Nature. 1962 May 5;194:495–496. [PubMed] [Google Scholar]
  • YALOW RS, BERSON SA. Immunoassay of endogenous plasma insulin in man. J Clin Invest. 1960 Jul;39:1157–1175.[PMC free article] [PubMed] [Google Scholar]
  • Herbert V, Lau KS, Gottlieb CW, Bleicher SJ. Coated charcoal immunoassay of insulin. J Clin Endocrinol Metab. 1965 Oct;25(10):1375–1384. [PubMed] [Google Scholar]
  • Arnaud CD, Tsao HS. Porcine calcitonin. Simple procedure for isolation in high yield. Biochemistry. 1969 Jan;8(1):449–456. [PubMed] [Google Scholar]
  • Rosselin G, Assan R, Yalow RS, Berson SA. Separation of antibody-bound and unbound peptide hormones labelled with iodine-131 by talcum powder and precipitated silica. Nature. 1966 Oct 22;212(5060):355–357. [PubMed] [Google Scholar]
  • Berson SA, Yalow RS. Radioimmunoassay of ACTH in plasma. J Clin Invest. 1968 Dec;47(12):2725–2751.[PMC free article] [PubMed] [Google Scholar]
  • Hoehn JG, Beahrs OH, Woolner LB. Unusual surgical lesions of the parathyroid gland. Am J Surg. 1969 Nov;118(5):770–778. [PubMed] [Google Scholar]
  • Arnaud CD, Tsao HS, Oldham SB. Native human parathyroid hormone: an immunochemical investigation. Proc Natl Acad Sci U S A. 1970 Sep;67(1):415–422.[PMC free article] [PubMed] [Google Scholar]
  • Sherwood LM, Mayer GP, Ramberg CF, Jr, Kronfeld DS, Aurbach GD, Potts JT., Jr Regulation of parathyroid hormone secretion: proportional control by calcium, lack of effect of phosphate. Endocrinology. 1968 Nov;83(5):1043–1051. [PubMed] [Google Scholar]
  • Ollayos RW, Winkler AW. URINARY EXCRETION AND SERUM CONCENTRATION OF INORGANIC PHOSPHATE IN MAN. J Clin Invest. 1943 Mar;22(2):147–154.[PMC free article] [PubMed] [Google Scholar]
  • Mautalen CA. Circadian rhythm of urinary total and free hydroxyproline excretion and its relation to creatinine excretion. J Lab Clin Med. 1970 Jan;75(1):11–18. [PubMed] [Google Scholar]
  • Berson SA, Yalow RS. Radioimmunoassays of peptide hormones in plasma. N Engl J Med. 1967 Sep 21;277(12):640–647. [PubMed] [Google Scholar]
Department of Endocrine Research, Mayo Clinic and Mayo Foundation, Rochester, Minnesota 55901
National Animal Disease Laboratory, Ames, Iowa 50010
Copyright notice
Abstract
A new radioimmunoassay for human parathyroid hormone (PTH) in serum, which can measure the hormone present in 94% of the normal sera tested, is described. It is based on the ability of human PTH to compete with I-labeled bovine PTH for binding to an antiserum directed against porcine PTH. This antiserum distinguishes between human PTH extracted from parathyroid adenomata and that present in hyperparathyroid sera. Evidence is given to suggest that this is due to immunochemical changes in the hormone extracted from adenomata and not to immunochemical heterogeneity of the hormone present in serum.
Physiologic data supporting the validity and specificity of the assay are presented. Induced episodes of hypercalcemia and hypocalcemia resulted in appropriate responses in serum immunoreactive PTH (IPTH) in normal subjects and in patients with Paget's disease of bone. In normals, there was a progressive increase in serum IPTH in the late afternoon and evening, suggesting a diurnal secretory rhythm. A negative correlation was found between the serum calcium and serum IPTH over the normal range of serum calcium values; a positive correlation was found between these variables in patients with primary hyperparathyroidism. There was apparent overlap between serum IPTH values in normal subjects and patients with primary hyperparathyroidism, but formal discriminate analysis of values for serum calcium and IPTH demonstrated separation of these two groups, without overlap.
Collaboration tool especially designed for Life Science professionals.Drag-and-drop any entity to your messages.